Gene: MYO1B
Official Full Name: myosin IBprovided by HGNC
Gene Summary: Enables ATP binding activity; actin filament binding activity; and microfilament motor activity. Involved in actin filament organization and post-Golgi vesicle-mediated transport. Located in several cellular components, including actin filament; endosome; and trans-Golgi network membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36564 | MYO1B Knockout cell line (HeLa) | Human | MYO1B | 1:3~1:6 | Negative | Online Inquiry |
KO36565 | MYO1B Knockout cell line (HCT 116) | Human | MYO1B | 1:2~1:4 | Negative | Online Inquiry |
KO36566 | MYO1B Knockout cell line (HEK293) | Human | MYO1B | 1:3~1:6 | Negative | Online Inquiry |
KO36567 | MYO1B Knockout cell line (A549) | Human | MYO1B | 1:3~1:4 | Negative | Online Inquiry |
MYO1B Gene Knockout Cell Lines are specialized cell lines engineered to have a targeted deletion of the MYO1B gene, which encodes a class I myosin motor protein involved in cellular processes such as endocytosis and organelle transport. The knockout of this gene allows researchers to explore the precise role of MYO1B in various biological pathways and cellular functions, aiding in the understanding of its contribution to cellular dynamics and integrity.
The primary function of these knockout cell lines is to serve as a robust model for investigating the phenotypic consequences of MYO1B disruption. The lack of the MYO1B protein facilitates the study of its mechanisms of action, particularly in the context of cell motility and intracellular trafficking. By observing changes in cellular behavior, researchers can gain insights into the molecular interactions and pathways regulated by MYO1B, significantly contributing to the fields of cytology and molecular biology.
The scientific importance of MYO1B Gene Knockout Cell Lines extends into various research domains, including cancer biology, neurobiology, and cell signaling. In clinical settings, understanding the function of MYO1B can lead to advancements in targeted therapies for diseases where this myosin is implicated, highlighting its potential as a drug target.
What sets our MYO1B Gene Knockout Cell Lines apart from other models is the precision and efficacy of our gene editing techniques, ensuring high specificity in gene disruption. Our product offers verified knockout efficiency, thus providing reliable and reproducible results that are crucial for impactful research. Moreover, these cell lines are compatible with various assay formats, making them versatile tools for researchers.
For researchers and clinicians looking to deepen their understanding of myosin-related cellular functions or develop novel therapeutic approaches, our MYO1B Gene Knockout Cell Lines present a valuable asset. Our company boasts a strong background in genetic engineering and cellular biology, ensuring that our products meet the highest standards of quality and reliability to support cutting-edge research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.